Showing results (1021-1030 of 3,660) with videos related to

Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|April 26, 2025
"Microsurgical breast reconstruction - A salvage option for failed implant-based breast reconstruction"Amir Khosrow Bigdeli, Jia Wei Tee, Felix Hubertus Vollbach, et al.
Breast (Edinburgh, Scotland)|April 16, 2025
Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 studyMatheus de Oliveira Andrade, Isabella Gonçalves Gutierres, Monique Celeste Tavares, et al.
Breast (Edinburgh, Scotland)|March 30, 2025
Patient perception on risk of recurrence and decision-making in the management of HER2-positive early breast cancer: Insights from the ASKHER2 European surveyMatteo Lambertini, Christian Jackisch, Olivier Trédan, et al.
Breast (Edinburgh, Scotland)|March 30, 2025
Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer RegistryTomoe Taji, Hiraku Kumamaru, Yuki Kataoka, et al.
Breast (Edinburgh, Scotland)|March 28, 2025
Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2- early breast cancerWolfgang Janni, Michael Untch, Nadia Harbeck, et al.
Breast (Edinburgh, Scotland)|May 27, 2025
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitorsRoberta Scafetta, Marco Donato, Carla Gullotta, et al.
Breast (Edinburgh, Scotland)|May 27, 2025
Advancing breast cancer therapy in the era of molecular diagnosticsMaria Grazia Carnevale, Riccardo Ray Colciago, Maria Carmen De Santis, et al.
Breast (Edinburgh, Scotland)|May 22, 2025
Clinical genome sequencing in patients with hereditary breast and ovarian cancer: Concept, implementation and benefitsDennis Witt, Marc Sturm, Antje Stäbler, et al.
Breast (Edinburgh, Scotland)|February 11, 2026
Treatment patterns and clinical outcomes according to PD-L1 status in >2000 patients with early-stage or metastatic triple-negative breast cancer treated in the real-world setting: VANESSA study resultsLazar Popovic, Romualdo Barroso-Sousa, Nagi S El Saghir, et al.
Breast (Edinburgh, Scotland)|February 14, 2026
Surgeon seniority and performance in breast-conserving surgery for non-palpable lesions: evidence from a multicenter studyFabio Corsi, Maria Luisa Gasparri, Sara Albasini, et al.
Pageof 366